Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP827170.RAKnW6AbUSUgELqJQ7SB1w1cP8sY6rUlSoHH94nUXSNG0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP827170.RAKnW6AbUSUgELqJQ7SB1w1cP8sY6rUlSoHH94nUXSNG0130_assertion type Assertion NP827170.RAKnW6AbUSUgELqJQ7SB1w1cP8sY6rUlSoHH94nUXSNG0130_head.
- NP827170.RAKnW6AbUSUgELqJQ7SB1w1cP8sY6rUlSoHH94nUXSNG0130_assertion description "[Despite a growing body of evidence concerning the gene structures responsible for genetically heterogenous CMT2B and other CMT2 neuropathies, little is known about the in vitro neuropathy model and how CMT2B-associated mutation-caused aberrant neuritogenesis is properly reversed.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP827170.RAKnW6AbUSUgELqJQ7SB1w1cP8sY6rUlSoHH94nUXSNG0130_provenance.
- NP827170.RAKnW6AbUSUgELqJQ7SB1w1cP8sY6rUlSoHH94nUXSNG0130_assertion evidence source_evidence_literature NP827170.RAKnW6AbUSUgELqJQ7SB1w1cP8sY6rUlSoHH94nUXSNG0130_provenance.
- NP827170.RAKnW6AbUSUgELqJQ7SB1w1cP8sY6rUlSoHH94nUXSNG0130_assertion SIO_000772 20645406 NP827170.RAKnW6AbUSUgELqJQ7SB1w1cP8sY6rUlSoHH94nUXSNG0130_provenance.
- NP827170.RAKnW6AbUSUgELqJQ7SB1w1cP8sY6rUlSoHH94nUXSNG0130_assertion wasDerivedFrom befree-2016 NP827170.RAKnW6AbUSUgELqJQ7SB1w1cP8sY6rUlSoHH94nUXSNG0130_provenance.
- NP827170.RAKnW6AbUSUgELqJQ7SB1w1cP8sY6rUlSoHH94nUXSNG0130_assertion wasGeneratedBy ECO_0000203 NP827170.RAKnW6AbUSUgELqJQ7SB1w1cP8sY6rUlSoHH94nUXSNG0130_provenance.